2017-08-17 13:16:41 UTC

Risk Factors of Prednisolone May Outweigh Benefit in Treatment of Severe Alcoholic Hepatitis (SAH)

Aug. 17, 2017

Gastroenterology researchers discuss their findings in video abstract.

Prednisolone is advocated for treatment of severe alcoholic hepatitis (SAH), but can increase susceptibility to infection. In the video below, Mark Thusz, MD,  Stephen Atkinson  and Nikhil Vergis, BMBCH, MRCP, discuss their findings, “In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA,” published in Gastroenterology


More on Hepatitis (other)

Building Foundations Among Payers & Providers for Collaborative Care in HCV & HIV

Dec. 7, 2017

In this video, leading experts in HCV, HIV, and managed care engage in a crossfire panel discussion on key challenges, considerations and solutions for improving patient management, and appropriate access to HCV and HIV therapies.

Previously Cured HCV Patients Can Be Reinfected

Aug. 3, 2017

Prevention will require attention to high-risk behaviors.

Make an Impact on World Hepatitis Day

July 27, 2017

World Hepatitis Day, July 28, is an opportunity to join in on the fight to end viral hepatitis.